{"id":945,"date":"2021-04-29T05:28:40","date_gmt":"2021-04-29T05:28:40","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=945"},"modified":"2021-04-29T05:28:40","modified_gmt":"2021-04-29T05:28:40","slug":"02-apr-2021-tocilizumab-was-found-effective-in-severely-or-critically-ill-covid-19-patients-with-raised-il-6-levels","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/02-apr-2021-tocilizumab-was-found-effective-in-severely-or-critically-ill-covid-19-patients-with-raised-il-6-levels\/","title":{"rendered":"(02 Apr 2021) Tocilizumab- was found effective in severely or critically ill COVID-19 patients with raised IL-6 levels"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p>Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients<\/p>\n<p class=\"\">https:\/\/doi.org\/10.5005\/jp-journals-10071-23747<\/p>\n<p class=\"\">All patients of the study group had symptomatic presentations with a mean PaO(2)\/FiO2 (P\/F) ratio of 205.41 before TCZ infusion. All patients had a raised IL-6 level (mean value 206.56 pg\/mL) that was extremely elevated in 90% of patients. Infusion of TCZ dramatically reduced mean body temperature (100.78-99.32 degrees F) and the requirement for supplemental oxygen (68-48%) and improved mean SpO2 (86-89%) and mean P\/F ratio (208-240) within 24 hours. Three patients on noninvasive ventilation were weaned off after TCZ infusion. Serum levels of IL-6 were raised initially but declined within 3-5 days of post-TCZ infusion. Conclusion: TCZ appears to be an effective therapeutic option in severely or critically ill COVID-19 patients with raised IL-6 levels. TCZ immediately improves the clinical status of patients by a probable mechanism of inhibition of cytokine storm and reduces COVID-19-related mortalities.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients https:\/\/doi.org\/10.5005\/jp-journals-10071-23747 All patients of the study group had symptomatic presentations with a mean PaO(2)\/FiO2 (P\/F) ratio of 205.41 before TCZ infusion. All patients had a raised IL-6 level (mean&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/02-apr-2021-tocilizumab-was-found-effective-in-severely-or-critically-ill-covid-19-patients-with-raised-il-6-levels\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(02 Apr 2021) Tocilizumab- was found effective in severely or critically ill COVID-19 patients with raised IL-6 levels&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[4,18,1],"tags":[27],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/945"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=945"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/945\/revisions"}],"predecessor-version":[{"id":947,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/945\/revisions\/947"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=945"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=945"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=945"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}